Inogen (INGN) Net Cash Flow (2013 - 2026)
Inogen (INGN) posted quarterly Net Cash Flow of -$10.8 million for Q1 2026, down 310.48% year-over-year from $5.1 million in Q1 2025, and down 307.52% quarter-over-quarter from -$2.6 million in Q4 2025.
Inogen (INGN) Net Cash Flow (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Net Cash Flow for 14 consecutive years, with -$10.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 310.48% year-over-year to -$10.8 million; the TTM figure through Mar 2026 stood at -$29.1 million (down 291.33% YoY), while the FY2025 annual figure was -$13.2 million, down 69.87% from the prior year.
- Net Cash Flow eased to -$10.8 million in Q1 2026 per INGN's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $10.3 million in Q2 2022 and bottomed at -$43.2 million in Q3 2023.
- Historically, Net Cash Flow has averaged -$8.3 million across 5 years, with a median of -$5.9 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 574.98% — and 2024, when it jumped 755.28%.
- Inogen's Net Cash Flow stood at -$22.5 million in 2022, then surged by 104.29% to $966000.0 in 2023, then surged by 755.28% to $8.3 million in 2024, then tumbled by 132.03% to -$2.6 million in 2025, then plunged by 307.52% to -$10.8 million in 2026.
- Business Quant data shows INGN's Net Cash Flow at -$10.8 million in Q1 2026, -$2.6 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | -5.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.81 Mn |
| Jun 30, 2026 | -5.81 Mn |
| Mar 31, 2026 | -10.78 Mn |
| Mar 31, 2026 | -10.78 Mn |
| Dec 31, 2025 | -2.65 Mn |
| Dec 31, 2025 | -2.65 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | -18.22 Mn |
| Jun 30, 2025 | -18.22 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 8.26 Mn |
| Dec 31, 2024 | 8.26 Mn |
| Sep 30, 2024 | 7.74 Mn |
| Sep 30, 2024 | 7.74 Mn |
| Jun 30, 2024 | -5.89 Mn |
| Jun 30, 2024 | -5.89 Mn |
| Mar 31, 2024 | -17.91 Mn |
| Mar 31, 2024 | -17.91 Mn |